Showing results (281-290 of 399) with videos related to
Sort By:
Pageof 40
British Journal of Haematology|July 20, 2016
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remissionAndrew M Brunner, Shuli Li, Amir T Fathi, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Chronic Myelogenous Leukemia, Version 1.2014Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.Blood Advances|January 10, 2024
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AMLJacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.Haematologica|January 29, 2026
Hypomethylating agents plus venetoclax versus intensive chemotherapy in acute myeloid leukemia with chromosome 5 and 7 abnormalitiesLeora Boussi, Jan Philipp Bewersdorf, Yiwen Liu, et al.Science (New York, N.Y.)|October 29, 2011
Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapyTriona Ni Chonghaile, Kristopher A Sarosiek, Thanh-Trang Vo, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Chronic myelogenous leukemia, version 1.2015Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.Blood Advances|June 28, 2024
Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AMLJan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, et al.Cancer Research|September 6, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerRyohei Yoshida, Maria Saigi, Tetsuo Tani, et al.Cancer Cell|September 12, 2018
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRASShunsuke Kitajima, Hajime Asahina, Ting Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.Pageof 40